Lipicure 30 Tablet contains Atorvastatin 30mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia, including elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, as well as reduced high-density lipoprotein cholesterol (HDL-C). Atorvastatin functions by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, resulting in decreased cholesterol production and increased clearance of LDL from the bloodstream. This mechanism contributes to the reduction of atherosclerotic plaque formation and lowers the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with established coronary heart disease or those at high risk. Lipicure 30 is typically prescribed as part of a comprehensive treatment plan including diet, exercise, and lifestyle modifications. The dosage should be individualized based on patient response and lipid profile, with regular monitoring of liver function tests and lipid levels recommended to ensure safety and efficacy. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances. Caution is advised in patients with hepatic impairment or a history of muscle disorders.